Better Buy: Canopy Growth Corporation vs. Scotts Miracle-Gro Company

A big marijuana grower. A big marijuana supplier. Which stock wins in a head-to-head matchup?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This article was originally published on Fool.com

When most investors think about marijuana stocks, one like Canopy Growth Corporation(NYSE:CGC) probably comes to mind. The company cultivates and produces cannabis products, including flower and oils. But while The Scotts Miracle-Gro Company (NYSE:SMG)is still best known for its consumer lawn and garden products, it too has become a marijuana stock by emerging as the leading supplier to the U.S. cannabis industry.

There’s no contest between these two stocks when it comes to year-to-date performance. Canopy Growth is up close to 80%. Scotts is down more than 25%. But which of these stocks is the better choice for long-term investors?

Tiny figures pushing wheelbarrows with marijuana buds on top of 20 dollar bills in a dollar sign money clip

IMAGE SOURCE: GETTY IMAGES.

The case for Canopy Growth

Any argument about the merits of investing in Canopy Growth has to start with the tremendous growth opportunity for the global cannabis industry. Countries around the world have legalized medical marijuana. Canada and Uruguay have legalized recreational marijuana, along with 10 U.S. states plus the District of Columbia. Some project that the global marijuana market will top $100 billion and perhaps a lot more within the next 15 years.

Canopy Growth appears to be in the best position of any company to capitalize on this market. It currently has 4.3 million square feet of licensed growing space in Canada. With its subsidiaries, Canopy claims a whopping 5.6 million square feet of growing space.

Production capacity is one key to success for Canopy Growth. Its distribution channels are another. Canopy lined up supply agreements for the recreational marijuana market in all of Canada’s provinces and territories that have announced supply plans. The company is moving forward aggressively with its retail strategy as well.

Earlier this year, major alcoholic-beverage company Constellation Brands invested $4 billion in Canopy Growth, boosting its stake in Canopy to 38% with an option to acquire even more shares. This deal solidified Canopy Growth’s status as the leading player in the cannabis industry and gave the company a big cash stockpile to expand its operations. Constellation Brands and Canopy Growth plan to launch cannabis-infused beverages in Canada when regulations are finalized for these types of products. 

Canopy Growth already has a presence in multiple international medical marijuana markets, including Australia, South America, Africa, and Europe, particularly in Germany. The company is poised to enter any other countries with federal laws that allow the legal sales of marijuana.   

The case for Scotts Miracle-Gro

Growth for the global cannabis industry is also a key part of the investing thesis for Scotts Miracle-Gro. But the focus for Scotts is on the U.S. market.

That’s actually a big plus for Scotts. The U.S. currently generates roughly 85% of total legal marijuana sales worldwide. That percentage will decline somewhat over the next few years as the markets in other countries expand. But the U.S. will continue to be the big prize for marijuana businesses for a long time to come.

Thanks to a string of acquisitions, Scotts Miracle-Gro has become the go-to supplier for U.S. marijuana growers. The company’s Hawthorne Gardening subsidiary provides a wide range of products, including fertilizers, hydroponics, lighting systems, irrigation systems, and ventilation systems.

Hawthorne Gardening makes the lion’s share of its money now in California. That’s not surprising, since it’s the largest marijuana market in the U.S. by far. However, the company has tremendous growth potential in other states — especially those that legalize recreational marijuana.

Still, Scotts Miracle-Gro’s marijuana-focused business generates only around 8% of the company’s total revenue. The rest comes from its core lawn and garden business. Scotts is launching new products and raise prices in 2019, moves that should boost its revenue. And with warmer weather conditions likely in future years, the company’s lawn and garden sales could enjoy solid growth.

There’s one more reason for investors to like Scotts Miracle-Gro as well — its dividend. Scotts’ dividend currently yields 3.11%, a nice bonus on top of the company’s growth prospects.

Better buy

If you’re a more conservative investor, Scotts Miracle-Gro is probably the better pick for you. The company generates a steady cash flow, it’s profitable, and it pays out a solid dividend. 

On the other hand, more aggressive growth investors will probably like Canopy Growth. If the global marijuana market gets anywhere close to the levels many expect, Canopy will skyrocket. The major downside for Canopy Growth is that its valuation already assumes a lot of growth. Should anything arise that derails the company’s growth trajectory, its stock would almost certainly plunge.

But trading off risk for reward comes with the territory for investors. For those who don’t want to take on as much risk, go with Scotts Miracle-Gro. For investors comfortable with higher levels of risk, consider Canopy Growth. Both marijuana stocks should be winners over the long run.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool US recommends Constellation Brands. The Motley Fool has a disclosure policy.

 

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »